🟢 Indaptus Therapeutics is trading 5.9% up in pre-market after announcing $24 million private placement

Indaptus Therapeutics is trading 5.9% up now at $2.71 after announcing a roughly $24 million private placement of approximately 20.3 million shares on September 10, 2026.

• The financing is intended to support working capital, research and development, general corporate purposes, and preclinical sleep-related neurotechnology evaluation.
• It is the clearest company-specific catalyst; stronger broader-market futures may provide support.
• Sharp rally: $1.13 on September 1 to $2.56 on September 10; limited coverage and financing-related dilution remain risks.